| Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models S Bhattacharya, K Calar, P de la Puente Journal of Experimental & Clinical Cancer Research 39 (1), 75, 2020 | 75 | 2020 |
| Bioengineering the oxygen-deprived tumor microenvironment within a three-dimensional platform for studying tumor-immune interactions S Bhattacharya, K Calar, C Evans, M Petrasko, P De la Puente Frontiers in Bioengineering and Biotechnology 8, 1040, 2020 | 27 | 2020 |
| Analysis of dual class I histone deacetylase and lysine demethylase inhibitor domatinostat (4SC-202) on growth and cellular and genomic landscape of atypical teratoid/rhabdoid MM Hoffman, JS Zylla, S Bhattacharya, K Calar, TW Hartman, ... Cancers 12 (3), 756, 2020 | 27 | 2020 |
| Anti-diabetic activity of Lagenaria siceraria pulp and seed extract in normal and alloxan-induced diabetic rats S Bhattacharya, B Das International Journal of Pharmaceutical sciences and Research 3 (9), 3362, 2012 | 24 | 2012 |
| Human plasma-derived 3D cultures model breast cancer treatment responses and predict clinically effective drug treatment concentrations K Calar, S Plesselova, S Bhattacharya, M Jorgensen, P de la Puente Cancers 12 (7), 1722, 2020 | 17 | 2020 |
| Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer MSM Zylla JLS, Hoffman MM, Plesselova S, Bhattacharya S, Calar K, Afeworki Y ... Cancers 14 (7), 1753, 2022 | 8 | 2022 |
| Bioengineering a novel 3D in-vitro model to recreate physiological oxygen levels and tumor-immune interactions S Bhattacharya, K Calar, C Evans, M Petrasko, P de la Puente bioRxiv, 828145, 2019 | 6 | 2019 |
| The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib A Sánchez‐Fdez, S Matilla‐Almazán, JC Montero, S Del Carmen, M Abad, ... Clinical and Translational Medicine 13 (4), e1217, 2023 | 4 | 2023 |
| Advances in animal models and cutting-edge research in alternatives: Proceedings of the second international conference on 3Rs research and progress, hyderabad, 2021 A Sonawane, B Vadloori, S Poosala, H Kandarova, M Kulkarni, ... Alternatives to Laboratory Animals 50 (2), 156-171, 2022 | 3 | 2022 |
| Kinetics of extracellular matrix (ECM) protein release from cornea following epithelial injury and its relevance to wound repair S BHATTACHARYA, G Chandrasekher Investigative Ophthalmology & Visual Science 57 (12), 4352, 2016 | 1 | 2016 |
| De Novo Design and In-Silico Studies of Some Novel Dipeptidyl-Peptidase IV Inhibitors H Sarkar, R Koley, S Dolui, S Bhattacharya Journal of Pharmacy Research 5 (12), 2012 | 1 | 2012 |
| Three-Dimensional Cross-Linked Scaffolds Of Peripheral Blood Plasma And Their Use P de la Puente, S Bhattacharya, K Calar US Patent App. 17/612,142, 2022 | | 2022 |
| Three-dimensional cross-linked scaffolds of peripheral blood plasma and their use K Bhattacharya, Somshuvra, Calar, P De la Puente WO Patent WO 2020/252444 A1, 2020 | | 2020 |
| Tissue-derived biomaterial composition and methods for ocular and other therapeutic applications G Chandrasekher, S Bhattacharya US Patent 10,765,776, 2020 | | 2020 |
| Feasibility and efficacy of a human-derived plasma 3D culture (huP3D) model to predict clinically effective drug treatment concentrations. K Calar, S Plesselova, S Bhattacharya, P de la Puente CANCER RESEARCH 80 (11), 43-44, 2020 | | 2020 |
| Abstract B29: Modeling the oxygen-deprived breast cancer tumor microenvironment within a three-dimensional bioengineered platform that exhibits hypoxia-driven immune evasion S Bhattacharya, K Calar, C Evans, P de la Puente Cancer Research 80 (11_Supplement), B29-B29, 2020 | | 2020 |
| Abstract A22: Feasibility and efficacy of a human-derived plasma 3D culture (huP3D) model to predict clinically effective drug treatment concentrations K Calar, S Plesselova, S Bhattacharya, P de la Puente Cancer Research 80 (11_Supplement), A22-A22, 2020 | | 2020 |
| Modeling the oxygen-deprived breast cancer tumor microenvironment within a three dimensional bioengineered platform that exhibits hypoxia-driven immune evasion. S Bhattacharya, C Calar, Kristin, Evans, M Petrasko, P de la Puente AACR The evolving landscape of cancer modeling, 2020 | | 2020 |
| Characterization of a novel biomaterial for the repair or replacement of pathological cornea G Chandrasekher, S Bhattacharya Investigative Ophthalmology & Visual Science 60 (9), 4115-4115, 2019 | | 2019 |
| Development of tissue-derived biomaterial ‘cornea-ecmix’: its utility in the management of corneal diseases S Bhattacharya South Dakota State University, 2019 | | 2019 |
